Warren Whitley
Optometrist · Sparks, NVNPI 1033494182
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Alcon at 27.5% of the total. Reporting peaked in 2022 at $852 and has fallen 66.8% since, to $283 in 2025. Among optometrist clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $28.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Sun Pharmaceutical Industries Inc.$724
- Bausch & Lomb Americas Inc.$544
- AbbVie$509
- Kala Pharmaceuticals, Inc.$274
- Johnson & Johnson Surgical Vision, Inc.$198
- plus $902 from 13 others
What the payments were for
- Food & beverage$4,344100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 35 | $1,193 |
| Sun Pharmaceutical Industries Inc. | 27 | $724 |
| Bausch & Lomb Americas Inc. | 14 | $544 |
| AbbVie | 13 | $509 |
| Kala Pharmaceuticals, Inc. | 30 | $274 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $198 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $144 |
| Carl Zeiss Meditec USA, Inc. | 1 | $140 |
| Biotissue Holdings Inc. | 4 | $113 |
| Apellis Pharmaceuticals, Inc. | 1 | $90 |
| Carl Zeiss Meditec, Inc. | 1 | $82 |
| Aerie Pharmaceuticals, Inc. | 4 | $76 |
| Heru, Inc. | 1 | $67 |
| Dompe US, Inc. | 2 | $48 |
| Novartis | 2 | $39 |
| Shire North American Group Inc | 2 | $34 |
| Tarsus Pharmaceuticals, Inc. | 1 | $25 |
| Tearlab Corp | 1 | $23 |
| Eyevance Pharmaceuticals LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,344 in reported general payments places this provider in the 90th percentile of 494 optometrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorometholone | 14 | $787 |
| ErythromycinErythromycin Base | 16 | $150 |
| Latanoprost | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Sparks
- Douglas DevriesSparks$1.3M
- Troy HumphreysSparks$52K
- Mackenzie MacintyreSparks$6K
- Timothy HunttingSparks$6K
- Benjamin CheungSparks$4K
- Stella LauNorth Las Vegas$100K
- Eric BrookerLas Vegas$53K
- My VuongLas Vegas$47K
- Chen YoungLas Vegas$46K
- Harlan KopolowLas Vegas$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.